Related Experiment Video
Updated: May 19, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity
1Second Affiliated Hospital of Harbin Medical University Heilongjiang 150086, PR China.
Abstract:
The knockdown of Bmi-1 could effectively suppress cancer cell proliferation and tumourigenicity in several cancers. This study aims to investigate whether or not Bmi-1 plays a causative role in the proliferation of ovarian epithelial cancer cells and telomerase activity. The messenger RNA (mRNA) and protein expression levels of Bmi-1 in the human ovarian carcinoma cell line OVCAR-3 were downregulated by Bmi-1 siRNA, as confirmed by real-time polymerase chain reaction (PCR) and Western blot. Cell viability was analysed by MTT assay, and telomerase activity was analysed by a modified telomeric repeat amplification protocol. Targeting Bmi-1 with siRNA inhibited Bmi-1 mRNA over five-fold compared with the control cells, and inhibited Bmi-1 protein expression over three-fold compared with control cells. The viability of the OVCAR-3 ovarian cancer cell line was reduced by Bmi-1 mRNA compared to control cells. Telomerase activity was decreased 22.73% (from 0.33 to 0.255) by Bmi-1 siRNA treatment compared to control cells. As Bmi-1 siRNA depressed telomerase activity, cell immortalisation may be prevented; thus, silencing Bmi-1 may be a potential therapy to manage ovarian cancer.
Insights
Silencing Bmi-1 (a key protein) significantly reduced ovarian cancer cell growth and telomerase activity. This suggests targeting Bmi-1 could be a promising new therapy for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bmi-1 is implicated in cancer cell proliferation and tumor formation.
- Its role in ovarian epithelial cancer and telomerase activity requires further investigation.
Purpose of the Study:
- To determine if Bmi-1 causally affects ovarian epithelial cancer cell proliferation.
- To investigate the impact of Bmi-1 on telomerase activity in ovarian cancer cells.
Main Methods:
- Ovarian carcinoma cell line (OVCAR-3) treated with Bmi-1 siRNA to downregulate Bmi-1 expression.
- Real-time PCR and Western blot used to confirm mRNA and protein downregulation.
- MTT assay for cell viability and modified telomeric repeat amplification protocol for telomerase activity.
Main Results:
- Bmi-1 siRNA inhibited Bmi-1 mRNA over five-fold and protein expression over three-fold.
- Ovarian cancer cell viability was significantly reduced.
- Telomerase activity decreased by 22.73% post-Bmi-1 siRNA treatment.
Conclusions:
- Bmi-1 downregulation suppresses ovarian cancer cell proliferation and viability.
- Silencing Bmi-1 reduces telomerase activity, potentially preventing cell immortalization.
- Targeting Bmi-1 represents a potential therapeutic strategy for ovarian cancer management.
Related Concept Videos
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Replicative Cell Senescence
Experimental RNAi
